Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18166
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNadebaum, David P-
dc.contributor.authorLee, Sze Ting-
dc.contributor.authorNikfarjam, Mehrdad-
dc.contributor.authorScott, Andrew M-
dc.date.accessioned2018-08-08T01:03:19Z-
dc.date.available2018-08-08T01:03:19Z-
dc.date.issued2018-07-
dc.identifier.citationWorld Journal of Nuclear Medicine 2018; 17(3): 195-197-
dc.identifier.issn1450-1147-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18166-
dc.description.abstract68Ga-DOTATATE positron emission tomography (PET) is a molecular imaging technology which has shown superiority over 111In-octreotide scanning for the detection and staging of neuroendocrine tumors. We report three patients with pancreatic masses that were ultimately diagnosed as clear cell renal cell carcinoma (ccRCC) metastases on histopathology. During their initial diagnostic assessment, the three patients underwent both 18F-fluorodeoxyglucose (18F-FDG) and 68Ga-DOTATATE PET. While all three patients' lesions showed variable 18F-FDG avidity, uptake on 68Ga-DOTATATE PET was comparatively intense. The small case series illustrates the need to consider ccRCC in the differential diagnosis of 68Ga-DOTATATE avid lesions.-
dc.language.isoeng-
dc.subject68Ga-DOTATATE-
dc.subjectkidney neoplasms-
dc.subjectpositron emission tomography-
dc.subjectrenal cell carcinoma-
dc.subjectsomatostatin receptors-
dc.titleMetastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature.-
dc.typeJournal Article-
dc.identifier.journaltitleWorld Journal of Nuclear Medicine-
dc.identifier.affiliationDepartment of Molecular Imaging and Therapy, Austin Health, the University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, La Trobe University, Melbourne, Victoria, Australia-
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.doi10.4103/wjnm.WJNM_38_17-
dc.identifier.orcid0000-0001-8641-456X-
dc.identifier.orcid0000-0003-4866-276X-
dc.identifier.orcid0000-0002-6656-295X-
dc.identifier.pubmedid30034285-
dc.type.austinJournal Article-
local.name.researcherLee, Sze Ting
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptSurgery (University of Melbourne)-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.